Reuters logo
BRIEF-Antibe Therapeutics advances development of ATB-352 in wake of growing global opioid epidemic
April 26, 2017 / 12:08 PM / 8 months ago

BRIEF-Antibe Therapeutics advances development of ATB-352 in wake of growing global opioid epidemic

April 26 (Reuters) - Antibe Therapeutics Inc:

* Antibe Therapeutics advances development of ATB-352 in wake of growing global opioid epidemic Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below